Risk Factors Associated with Acute Sarcopenia in Patients Hospitalized with COVID-19
Table 2
Relationship between acute sarcopenia and outcomes.
Variables
Acute sarcopenia
value
Yes (n = 34)
No (n = 179)
Age (M ± SD, years)
67 ± 14.4
55.5 ± 14.9
<0.001
Body weight (M; IQR, kg)
67 (59–79)
86 (78–100)
<0.001
Usual weight (M; IQR, kg)
71 (62–84)
89 (80–102)
<0.001
Unintentional weight loss (M; IQR, kg)
3 (3–5)
2 (2–3)
<0.001
Percentage of unintentional weight loss (M; I QR)
4.8 (3.1–6)
2.5 (2.0–3.8)
<0.001
SARC-F (M; IQR, points)
5 (4–6)
4 (1–5)
<0.001
Handgrip strength (M; IQR, kg)
21 (16.2–26.2)
32 (25.3–39)
<0.001
Calf circumference (M; IQR, cm)
31.4 (29.3–32.9)
37.3 (34.8–41.5)
<0.001
PCR (M; IQR, mg/L)
92 (52–127)
94 (50–150)
0.397
Days of signs/symptoms of prehospitalization (M; IQR)
8 (6–15)
9 (7–11)
0.607
LOS (M; IQR, days)
9 (7–14)
11 (5–19)
0.943
SARC-F: strength, assistance with walking, rise from a chair, climb stairs, fall; PCR: C-reactive protein; LOS: length of stay. Statistic presented: mean and standard deviation (M + SD) or median and interquartile range (M; IQR). Statistical test performed: Student’s t or Mann–Whitney test.
